Morgan Stanley Schedule 13G passive stakes

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed a Schedule 13G amendment indicating their beneficial ownership of Tactile Systems Technology Inc. common stock has fallen below the 5% reporting threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an updated Schedule 13G detailing their beneficial ownership of Sphere Entertainment Co. Class A Common Stock.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed a Schedule 13G, reporting beneficial ownership of 5.7% of Radware Ltd.'s ordinary shares as of June 30, 2026.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an amended Schedule 13G detailing their beneficial ownership of Nuveen Taxable Municipal Income Fund shares.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, indicating a reduction in their beneficial ownership of Nexpoint Diversified Real Estate Trust common shares to below the five percent threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting a decrease in their beneficial ownership of Magnera Corp's common stock to below the 5% threshold.

Morgan Stanley and its subsidiary have reported a decrease in their beneficial ownership of Cohen & Steers Select Preferred & Income Fund, Inc. common stock to below the 5% threshold.

Morgan Stanley entities have reported a decrease in their beneficial ownership of C4 Therapeutics, Inc. common stock, now holding less than 5% collectively.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an updated Schedule 13G, reporting a combined beneficial ownership of 14.1% in BlackRock 2037 Municipal Target Term Trust.

A group of entities affiliated with Morgan Stanley has reported beneficial ownership of 5,500,000 shares, representing 6.7% of the common stock of NN Inc.

Morgan Stanley and Parametric Portfolio Associates LLC have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 8.7% in Western Asset Emerging Markets Debt Fund Inc.

Morgan Stanley has filed a Schedule 13G amendment indicating its beneficial ownership of U.S. Physical Therapy Inc. common stock has fallen below the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than five percent of ProKidney Corp.'s Class A Common Stock.

Morgan Stanley and Parametric Portfolio Associates LLC have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 6.5% in NYLI CBRE Global Infrastructure Megatrends Term Fund.

Morgan Stanley and Atlanta Capital Management Company, LLC have updated their beneficial ownership filings for Choice Hotels International Inc., reporting changes in their holdings.

Morgan Stanley and Parametric Portfolio Associates LLC have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than five percent of CBRE Global Real Estate Income Fund's common shares.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have updated their Schedule 13G filing to reflect their beneficial ownership of Arbutus Biopharma Corp. common shares.

Morgan Stanley has updated its beneficial ownership filing for AptarGroup, Inc., reporting a 5.1% stake as of June 30, 2026.

Morgan Stanley and Atlanta Capital Management Company, LLC have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of Affiliated Managers Group, Inc. common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have reported a complete divestment of their beneficial ownership in XOMA Royalty Corp, holding 0.0% of the class of securities.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed a Schedule 13G detailing their beneficial ownership of XOMA Royalty Corp. common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an amended Schedule 13G, reporting beneficial ownership of 11.9% of BioVie Inc.'s Class A Common Stock.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed beneficial ownership of 8.0% of BioVie Inc.'s Class A Common Stock as of June 30, 2026.

Morgan Stanley and its subsidiary, Morgan Stanley & Co. LLC, have filed a Schedule 13G, reporting beneficial ownership of less than 5% of the Auction Preferred Stock of Eaton Vance Ltd Duration Income Fund.

Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC have filed a Schedule 13G, reporting beneficial ownership of less than 5% of MFS Charter Income Trust's common stock as of June 30, 2026.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed a Schedule 13G, indicating a reduction in their beneficial ownership of CervoMed Inc. common stock to below the 5% threshold.

Morgan Stanley has filed a Schedule 13G, indicating it no longer beneficially owns more than five percent of the common stock of MFS Investment Grade Municipal Trust.

Morgan Stanley has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Zepp Health Corp.

Morgan Stanley has filed an amendment indicating it no longer beneficially owns more than five percent of Terns Pharmaceuticals, Inc. common stock.

Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.3% beneficial ownership stake in Insight Enterprises, Inc.